Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
about
Effects of continuous versus cyclical oral contraception: a randomized controlled trialPharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringHormonal aspects of epilepsy.MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.Prenatal exposure to lamotrigine: effects on postnatal development and behaviour in rat offspringClinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptivesTherapeutic Drug Monitoring of the Newer Anti-Epilepsy MedicationsLamotrigine dosing for pregnant patients with bipolar disorder.Antiepileptic drug interactions - principles and clinical implications.Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term.The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine.Clinical therapeutics in pregnancy.Pregnancy, epilepsy, and anticonvulsants.Paracetamol pharmacokinetics and metabolism in young women.Hormones, seizures, and lamotrigine: Oh, my!2005 AES annual course: evidence used to treat women with epilepsy.Does increased levetiracetam clearance during pregnancy require planned intervention?Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.Pharmacokinetics of drugs in pregnancy.Women and epilepsy: review and practical recommendations.Alterations in drug disposition during pregnancy: implications for drug therapy.Value of therapeutic drug monitoring in epilepsy.Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancyDrug interactions involving the new second- and third-generation antiepileptic drugs.Contraception and antiepileptic drugs.Second-generation antiepileptic drugs and pregnancy: a guide for clinicians.Methodologies used to identify and characterize interactions among antiepileptic drugs.Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders.Anti-epileptic drugs and hormonal treatments.Reasons for discontinuation of reversible contraceptive methods by women with epilepsy.Menstrual Migraine and Treatment Options: Review.Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations: A matched case-control study.Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa.Women with epilepsy initiating a progestin IUD: A prospective pilot study of safety and acceptability.Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts.Rational combination therapy in refractory migraine.Sex related differences on valproic acid pharmacokinetics after oral single dose.The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism.
P2860
Q23920159-B9E3EE06-A98D-4316-ADE0-61FC4BF5A6BDQ27027293-C098B737-9C85-4DD8-A17E-AB495D64174BQ33638313-6A5BE5D4-C947-41C7-96EE-7E44B43435AAQ33683865-6BD8273F-2664-4FE8-9E4E-5BEA2D4570FBQ33711330-4F1E6981-BE1D-428C-960B-DE3FDD71DC02Q33765400-9B930E5B-AD3F-4CF2-8436-DF7138E1D05FQ33996679-F9EBD784-9095-4BE5-B778-78FADABDB302Q34131260-95D2F875-0C45-4483-819F-9711DCB0416BQ34402188-78BDA511-87A9-4A46-B36A-EF6AD10C608CQ34557203-0D2B4B4C-1600-44AD-8731-FBFDA1B442D3Q34830210-41AA002E-9E81-4820-8338-6A4D564DF0B8Q35113890-07A0683B-84C4-4946-BDBE-558E8B5057D6Q35236942-EBF10ECD-ABE2-4E91-BA1C-247D086D10B9Q35841159-C0038C9D-3AE9-43DD-8FFC-F93549C2D1BCQ36453496-AA0BA8C9-CFD9-4FA1-A109-5EBAD0154E36Q36625015-0D06FF50-6CA9-4C1E-858E-98D8AF40A0ACQ36658100-1958FD61-6F40-4DFB-AEFE-7A9BEAFC397AQ36660112-6CCA0A89-9C9E-48D4-9E01-D56B8A00E611Q36662898-1B6EC677-8913-4E39-93E5-D46FE13DE914Q36673011-FF46B322-AD0A-49C5-8B6B-BF9B33065C88Q36734138-0482D0EA-E796-4037-A922-F4245B3695F1Q36752925-799D564E-BF1F-4B27-BCE1-5816DB53294EQ36909328-79C22F10-6E7B-45F1-B28C-F9DBE1FED852Q37174056-B4D41D61-1EE3-4A1B-BD31-50A4BD05157FQ37311627-592E7831-B43B-4B78-8980-CC3F3A0F10A8Q37658910-C630B34B-8A84-4DE7-972A-47A891F2926AQ38010240-C06DB414-6858-4877-A03B-39E25850F799Q38014890-401FA151-E61E-462B-B134-8ECE990D5D27Q38018676-5D196EB5-29AA-45B7-BF59-EE6E617EF9BFQ38116456-3B897FB2-B3C5-4F2E-9E97-93636D76ADABQ38200537-672D4BE7-8D79-4EFE-8B55-69FC25742B6BQ38859883-59914C8E-04AC-427C-B2EA-F3DE1EB76F52Q39026779-A09B61C4-4F9B-44B9-B3B0-3B556D409472Q39224683-66A3BD45-0CB9-42F3-9FF0-7130640E0695Q39301817-130C7793-BA8C-4AE7-8150-49E4F0146734Q39345923-8D1B68B8-B8EC-45F8-851A-EBA8955A2330Q39510801-E4EF1E39-BDCD-4506-AD09-50C5ADA1406FQ40081930-CEFD0AAC-8635-4BC0-9E67-49D19D9690EFQ45229764-60F90BE4-2EE1-4948-A493-340456D301AAQ46587398-773953D2-D102-4EDE-9A81-D8826A10A5A0
P2860
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@ast
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@en
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@nl
type
label
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@ast
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@en
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@nl
prefLabel
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@ast
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@en
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.
@nl
P2860
P1433
P1476
Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations
@en
P2093
Eylert Brodtkorb
Grethe Helde
P2860
P304
P356
10.1111/J.1528-1167.2005.10105.X
P50
P577
2005-09-01T00:00:00Z